High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations

Moritz Fürstenau*, Yvonne J Thus, Sandra Robrecht, Clemens H M Mellink, Anne-Marie F van der Kevie-Kersemaekers, Julie Dubois, Julia von Tresckow, Michaela Patz, Michael Gregor, Patrick Thornton, Philipp B Staber, Tamar Tadmor, Mark-David Levin, Caspar da Cunha-Bang, Christof Schneider, Christian Bjørn Poulsen, Thomas Illmer, Björn Schöttker, Ann Janssens, Ilse ChristiansenThomas Noesslinger, Michael Baumann, Holger Hebart, Tobias Gaska, Josien Regelink, Ellen C Dompeling, Vesa Lindstrom, Gunnar Juliusson, Anouk Andrea Widmer, Jeroen S Goede, Neta Goldschmidt, Florian Simon, Nisha De Silva, Anna Maria Fink, Kirsten Fischer, Clemens-Martin Wendtner, Matthias Ritgen, Monika Brüggemann, Eugen Tausch, Marcel Spaargaren, Eric Eldering, Stephan Stilgenbauer, Carsten Utoft Niemann, Michael Hallek, Barbara Eichhorst, Karl-Anton Kreuzer, Arnon P Kater

*Corresponding author af dette arbejde
21 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations'. Sammen danner de et unikt fingeraftryk.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology